<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459463</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Maternal and Fetal Outcome of COVID-19 Infection among Pregnant Women.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1676</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60101676</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: Pregnant women face an increased risk of experiencing negative consequences due to COVID-19 infection. Our study aimed to identify outcomes for both mothers and fetuses associated with COVID-19 during each trimester, as well as to identify post-COVID symptoms in this population. <i>Materials and Methods</i>: Among the total population, 14 females were infected during the first trimester, 25 during the second, and 66 during the third trimester. Weekly follow-ups were conducted until delivery. Seventy-five females (71.4%; 95% CI:26.9-115.9%) were admitted to the hospital secondary to COVID-19 infection. Maternal hospitalization was independently associated with COVID-19 severity (adjusted odds ratio (aOR) = 3.9; 95% CI: 1.6-9.2 at <i>p</i> = 0.002 relative to the reference group (mild infection)) and the presence of dyspnea at initial assessment (aOR = 6.9; 95% CI: 1.7-28.2 at <i>p</i> = 0.007 relative to nondyspneic patients). <i>Results</i>: The duration of hospitalization (mean ± SD) was higher in the third trimester than the first and second trimesters (10.1 ± 0.8 vs. 4.0 ± 1.2 days and 10.1 ± 0.8 vs. 6.2 ± 1.4 days, respectively, at <i>p &lt;</i> 0.05). The number of maternal deaths in the third trimester was higher than in the first and second trimesters (16 (24.2%) vs. no deaths and 16 (24.2%) vs. 1 (4%) deaths, respectively, at <i>p &lt;</i> 0.05). In terms of fetal outcomes, a good fetal condition was more likely if the mother was infected during the first trimester (92.9%) than the second (80%) or third trimesters (66.7%), but the difference was not significant. The percentage of preterm deliveries was insignificantly higher in the second trimester (16%) than the first (7.1%) and third (4.5%) trimesters. <i>Conclusions:</i> The most common post-COVID symptoms included persistent loss of smell, dry eyes, post-partum depression, knee pain, and myalgia. Post-COVID symptoms were more prevalent in patients infected during the third trimester. The adverse outcomes of COVID-19 infection for both mother and fetus were more severe in cases where the infection occurred during the third trimester compared to the second and first trimesters. Therefore, it is crucial to adhere to precautionary measures against COVID-19, prioritize vaccination, and provide comprehensive care for pregnant mothers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khalil</LastName><ForeName>Eman M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madney</LastName><ForeName>Yasmin M</ForeName><Initials>YM</Initials><Identifier Source="ORCID">0000-0003-4105-7874</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahmy</LastName><ForeName>Alzhraa M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-7243-3006</Identifier><AffiliationInfo><Affiliation>Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Saud O</ForeName><Initials>SO</Initials><Identifier Source="ORCID">0000-0002-6251-3149</Identifier><AffiliationInfo><Affiliation>Department of Pharmacognosy and Alternative Medicine, Faculty of Pharmacy, Northern Border University, Rafha 76321, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Qamar A</ForeName><Initials>QA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Northern Border University, Rafha 76321, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou-Taleb</LastName><ForeName>Heba A</ForeName><Initials>HA</Initials><Identifier Source="ORCID">0000-0001-7655-2088</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Merit University (MUE), Sohag 82755, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Ahmed A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elgendy</LastName><ForeName>Marwa O</ForeName><Initials>MO</Initials><Identifier Source="ORCID">0000-0002-5466-0552</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Beni-Suef University Hospitals, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Faculty of Pharmacy, Nahda University (NUB), Beni Suef 62764, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Hamada A A</ForeName><Initials>HAA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medicine, Beni-Suef University, Beni-Suef 62521, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NBU-FFR-2024-2613-02</GrantID><Agency>Northern Border University, Arar, KSA</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="Y">Pregnancy Outcome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">fetus</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">three trimesters</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459463</ArticleId><ArticleId IdType="pmc">PMC11509149</ArticleId><ArticleId IdType="doi">10.3390/medicina60101676</ArticleId><ArticleId IdType="pii">medicina60101676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sayed A.M., Khalaf A.M., Abdelrahim M.E., Elgendy M.O. Repurposing of some anti-infective drugs for COVID-19 treatment: A surveillance study supported by an in silico investigation. Int. J. Clin. Pract. 2021;75:e13877. doi: 10.1111/ijcp.13877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13877</ArticleId><ArticleId IdType="pmc">PMC7883047</ArticleId><ArticleId IdType="pubmed">33300221</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawbaa H.M., Osama H., El-Gendy A., Saeed H., Harb H.S., Madney Y.M., Abdelrahman M., Mohsen M., Ali A.M., Nicola M. Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease. J. Med. Virol. 2022;94:197–204. doi: 10.1002/jmv.27293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27293</ArticleId><ArticleId IdType="pmc">PMC8661821</ArticleId><ArticleId IdType="pubmed">34427922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA. 2020;324:782–793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokken E.M., Walker C.L., Delaney S., Kachikis A., Kretzer N.M., Erickson A., Resnick R., Vanderhoeven J., Hwang J.K., Barnhart N. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am. J. Obstet. Gynecol. 2020;223:911.e1–911.e4. doi: 10.1016/j.ajog.2020.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.05.031</ArticleId><ArticleId IdType="pmc">PMC7234933</ArticleId><ArticleId IdType="pubmed">32439389</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokken E.M., Huebner E.M., Taylor G.G., Hendrickson S., Vanderhoeven J., Kachikis A., Coler B., Walker C.L., Sheng J.S., Al-Haddad B.J. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am. J. Obstet. Gynecol. 2021;225:77.e1–77.e4. doi: 10.1016/j.ajog.2020.12.1221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.12.1221</ArticleId><ArticleId IdType="pmc">PMC7838012</ArticleId><ArticleId IdType="pubmed">33515516</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistoni I., Francioni M., Morici N., Rubboli A., Podda G.M., Pappalardo A., Abdelrahim M.E., Elgendy M.O., Elgendy S.O., Khalaf A.M. Pre-and in-hospital anticoagulation therapy in coronavirus disease 2019 patients: A propensity-matched analysis of in-hospital outcomes. J. Cardiovasc. Med. 2022;23:264–271. doi: 10.2459/JCM.0000000000001284.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001284</ArticleId><ArticleId IdType="pubmed">34878430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael M.S., Elgendy M.O., Binsaleh A.Y., Saleh A., Abdelrahim M.E., Osama H. Impulsivity and Its Association with Depression and Anxiety in the Normal Egyptian Population Post COVID-19 Pandemic. Medicina. 2024;60:1367. doi: 10.3390/medicina60081367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina60081367</ArticleId><ArticleId IdType="pmc">PMC11356745</ArticleId><ArticleId IdType="pubmed">39202648</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J., Fernandez S., Bonet M., Stallings E., Yap M., Kew T., Zhou D., Coomar D., Sheikh J., Lawson H. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3320</ArticleId><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalano A., Iacopetta D., Ceramella J., Maio A.C.D., Basile G., Giuzio F., Bonomo M.G., Aquaro S., Walsh T.J., Sinicropi M.S. Are nutraceuticals effective in COVID-19 and post-COVID prevention and treatment? Foods. 2022;11:2884. doi: 10.3390/foods11182884.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11182884</ArticleId><ArticleId IdType="pmc">PMC9498392</ArticleId><ArticleId IdType="pubmed">36141012</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotakopoulos L., Myers T.R., Gee J., Lipkind H.S., Kharbanda E.O., Ryan D.S., Williams J.T., Naleway A.L., Klein N.P., Hambidge S.J. SARS-CoV-2 infection among hospitalized pregnant women: Reasons for admission and pregnancy characteristics—Eight US health care centers, March 1–May 30, 2020. Morb. Mortal. Wkly. Rep. 2020;69:1355. doi: 10.15585/mmwr.mm6938e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6938e2</ArticleId><ArticleId IdType="pmc">PMC7727498</ArticleId><ArticleId IdType="pubmed">32970660</ArticleId></ArticleIdList></Reference><Reference><Citation>Takemoto M.L., Menezes M.d.O., Andreucci C.B., Nakamura-Pereira M., Amorim M.M., Katz L., Knobel R. The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting. Int. J. Gynecol. Obstet. 2020;151:154–156. doi: 10.1002/ijgo.13300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13300</ArticleId><ArticleId IdType="pmc">PMC9087660</ArticleId><ArticleId IdType="pubmed">32644220</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim M.M.R., Takemoto M.L.S., da Fonseca E.B. Maternal deaths with coronavirus disease 2019: A different outcome from low-to middle-resource countries? Am. J. Obstet. Gynecol. 2020;223:298–299. doi: 10.1016/j.ajog.2020.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.04.023</ArticleId><ArticleId IdType="pmc">PMC7195009</ArticleId><ArticleId IdType="pubmed">32348744</ArticleId></ArticleIdList></Reference><Reference><Citation>Takemoto M.L., Menezes M.O., Andreucci C.B., Knobel R., Sousa L.A., Katz L., Fonseca E.B., Magalhães C.G., Oliveira W.K., Rezende-Filho J. Maternal mortality and COVID-19. J. Matern.-Fetal Neonatal Med. 2022;35:2355–2361. doi: 10.1080/14767058.2020.1786056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2020.1786056</ArticleId><ArticleId IdType="pubmed">32674646</ArticleId></ArticleIdList></Reference><Reference><Citation>Askary E., Poordast T., Shiravani Z., Ali M.A., Hashemi A., Naseri R., Moradialamdarloo S., Karimi Z., Izanloo E., Najib F.S. Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series. Int. J. Reprod. BioMedicine. 2021;19:191. doi: 10.18502/ijrm.v19i2.8477.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijrm.v19i2.8477</ArticleId><ArticleId IdType="pmc">PMC7922300</ArticleId><ArticleId IdType="pubmed">33718763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu N., Li W., Kang Q., Xiong Z., Wang S., Lin X., Liu Y., Xiao J., Liu H., Deng D. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: A retrospective, single-centre, descriptive study. Lancet Infect. Dis. 2020;20:559–564. doi: 10.1016/S1473-3099(20)30176-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30176-6</ArticleId><ArticleId IdType="pmc">PMC7158904</ArticleId><ArticleId IdType="pubmed">32220284</ArticleId></ArticleIdList></Reference><Reference><Citation>Eid R.A., Elgendy M.O., El-Gendy A.O., Elgendy S.O., Belbahri L., Sayed A.M., Rateb M.E. Efficacy of ceftazidime and cefepime in the management of COVID-19 patients: Single center report from Egypt. Antibiotics. 2021;10:1278. doi: 10.3390/antibiotics10111278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10111278</ArticleId><ArticleId IdType="pmc">PMC8614536</ArticleId><ArticleId IdType="pubmed">34827216</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hosari D.G., Hussein W.M., Elgendy M.O., Elgendy S.O., Ibrahim A.R., Fahmy A.M., Hassan A., Mokhtar F.A., Hussein M.F., Abdelrahim M.E. Galangal–cinnamon spice mixture blocks the coronavirus infection pathway through inhibition of SARS-CoV-2 MPro, three HCoV-229E targets; quantum-chemical calculations support in vitro evaluation. Pharmaceuticals. 2023;16:1378. doi: 10.3390/ph16101378.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16101378</ArticleId><ArticleId IdType="pmc">PMC10610207</ArticleId><ArticleId IdType="pubmed">37895849</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado K., Ayuk P. Post-COVID-19 condition and pregnancy. Case Rep. Women’s Health. 2023;37:e00458. doi: 10.1016/j.crwh.2022.e00458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crwh.2022.e00458</ArticleId><ArticleId IdType="pmc">PMC9622021</ArticleId><ArticleId IdType="pubmed">36338320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P.-H., Lee W.-L., Yang S.-T., Tsui K.-H., Chang C.-C., Lee F.-K. The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19. J. Chin. Med. Assoc. 2021;84:813–820. doi: 10.1097/JCMA.0000000000000595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCMA.0000000000000595</ArticleId><ArticleId IdType="pubmed">34369462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro H.F., de Barros Carvalho M.D., Pelloso F.C., Santos L.d., de Andrade Pereira Silva M., Stevanato K.P., Borghesan D.H.P., Romani I., Marques V.D., de Freitas K.M.S. Maternal Risk Factors Associated with Negative COVID-19 Outcomes and Their Relation to Socioeconomic Indicators in Brazil. Healthcare. 2023;11:2072. doi: 10.3390/healthcare11142072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11142072</ArticleId><ArticleId IdType="pmc">PMC10379003</ArticleId><ArticleId IdType="pubmed">37510513</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalaf A.M., Elgendy M.O., Fahmy A.M., El Gendy S.O., El-Gendy A.O., Abdelrahman M.A., El-Bahrawy A.H., Elsisi A.M.M., Shafiq S.N. Relation between ABO and RhD and prevalence and severity of COVID-19 disease. Int. J. Clin. Med. Res. 2024;2:78–86. doi: 10.61466/ijcmr2030003.</Citation><ArticleIdList><ArticleId IdType="doi">10.61466/ijcmr2030003</ArticleId></ArticleIdList></Reference><Reference><Citation>Eid R.A., Elgendy M.O., Sayed A.M., Abdallah A.M., Mostafa H.M., Elsisi A.M.M., Hamed A.M., Shaker M.A. Efficacy of Linezolid in the management of pneumonic COVID-19 patients. Bioinformatics-based clinical study. J. Infect. Dev. Ctries. 2024;18:326–331. doi: 10.3855/jidc.19205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.19205</ArticleId><ArticleId IdType="pubmed">38635606</ArticleId></ArticleIdList></Reference><Reference><Citation>Alatawi A.D., Elgendy M.O., Sayed A.M., Shafiq S.N., El-Bahrawy A.H., Mallhi T.H., Khan Y.H., Alzarea A.I., Alotaibi N.H., Alanazi A.S. Local and Systemic side effects of COVID-19 Vaccines. Int. J. Clin. Med. Res. 2023;2:11–20. doi: 10.61466/ijcmr2010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.61466/ijcmr2010002</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph N.T., Wylie B.J. Maternal deaths in Brazil from severe COVID-19 respiratory disease: Time for a global commitment to ending health disparities. BJOG. 2020;127:1627. doi: 10.1111/1471-0528.16521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.16521</ArticleId><ArticleId IdType="pmc">PMC7537235</ArticleId><ArticleId IdType="pubmed">32959491</ArticleId></ArticleIdList></Reference><Reference><Citation>Radan A.-P., Fluri M.-M., Nirgianakis K., Mosimann B., Schlatter B., Raio L., Surbek D. Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study. Diabetes Metab. 2022;48:101351. doi: 10.1016/j.diabet.2022.101351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2022.101351</ArticleId><ArticleId IdType="pmc">PMC9021127</ArticleId><ArticleId IdType="pubmed">35462041</ArticleId></ArticleIdList></Reference><Reference><Citation>Vousden N., Bunch K., Morris E., Simpson N., Gale C., O’Brien P., Quigley M., Brocklehurst P., Kurinczuk J.J., Knight M. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS) PLoS ONE. 2021;16:e0251123. doi: 10.1371/journal.pone.0251123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251123</ArticleId><ArticleId IdType="pmc">PMC8099130</ArticleId><ArticleId IdType="pubmed">33951100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Mei H., Zheng T., Fu Q., Zhang Y., Buka S., Yao X., Tang Z., Zhang X., Qiu L. Pregnant women with COVID-19 and risk of adverse birth outcomes and maternal-fetal vertical transmission: A population-based cohort study in Wuhan, China. BMC Med. 2020;18:1–7. doi: 10.1186/s12916-020-01798-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01798-1</ArticleId><ArticleId IdType="pmc">PMC7568966</ArticleId><ArticleId IdType="pubmed">33070775</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadi P., Alipour Z., Ghaedrahmati M., Ahangari R. The severity of COVID-19 among pregnant women and the risk of adverse maternal outcomes. Int. J. Gynecol. Obstet. 2021;154:92–99. doi: 10.1002/ijgo.13700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13700</ArticleId><ArticleId IdType="pmc">PMC9087550</ArticleId><ArticleId IdType="pubmed">33834499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dileep A., ZainAlAbdin S., AbuRuz S. Investigating the association between severity of COVID-19 infection during pregnancy and neonatal outcomes. Sci. Rep. 2022;12:3024. doi: 10.1038/s41598-022-07093-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07093-8</ArticleId><ArticleId IdType="pmc">PMC8863811</ArticleId><ArticleId IdType="pubmed">35194128</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J.L., Nguyen L.M., Noble K.N., Aronoff D.M. COVID-19-related disease severity in pregnancy. Am. J. Reprod. Immunol. 2020;84:e13339. doi: 10.1111/aji.13339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aji.13339</ArticleId><ArticleId IdType="pubmed">32885539</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaraj S.H., Al-Tawfiq J.A., Memish Z.A. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of the literature. J. Microbiol. Immunol. Infect. 2019;52:501–503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128238</ArticleId><ArticleId IdType="pubmed">29907538</ArticleId></ArticleIdList></Reference><Reference><Citation>Vouga M., Favre G., Martinez-Perez O., Pomar L., Acebal L.F., Abascal-Saiz A., Hernandez M.R.V., Hcini N., Lambert V., Carles G. Maternal outcomes and risk factors for COVID-19 severity among pregnant women. Sci. Rep. 2021;11:13898. doi: 10.1038/s41598-021-92357-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92357-y</ArticleId><ArticleId IdType="pmc">PMC8260739</ArticleId><ArticleId IdType="pubmed">34230507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellington S., Strid P., Tong V.T., Woodworth K., Galang R.R., Zambrano L.D., Nahabedian J., Anderson K., Gilboa S.M. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. Morb. Mortal. Wkly. Rep. 2020;69:769. doi: 10.15585/mmwr.mm6925a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6925a1</ArticleId><ArticleId IdType="pmc">PMC7316319</ArticleId><ArticleId IdType="pubmed">32584795</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A., Elgendy M.O., Abdelrahman M.A., Ali H., Khalil E.M., Hassan M., Fahmy A.M., Gad R.A., Salem H.F. The Efficacy of Using Different Antibiotics to Prevent Maternal Surgical Site Infections in COVID-19-Infected Cases. Eur. Chem. Bull. 2023;6:1342–1348.</Citation></Reference><Reference><Citation>Pierce-Williams R.A., Burd J., Felder L., Khoury R., Bernstein P.S., Avila K., Penfield C.A., Roman A.S., DeBolt C.A., Stone J.L. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: A United States cohort study. Am. J. Obstet. Gynecol. MFM. 2020;2:100134. doi: 10.1016/j.ajogmf.2020.100134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100134</ArticleId><ArticleId IdType="pmc">PMC7205698</ArticleId><ArticleId IdType="pubmed">32391519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassi Z.S., Ali A., Das J.K., Salam R.A., Padhani Z.A., Irfan O., Bhutta Z.A. A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity. J. Glob. Health. 2021;11:05018. doi: 10.7189/jogh.11.05018.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.11.05018</ArticleId><ArticleId IdType="pmc">PMC8248750</ArticleId><ArticleId IdType="pubmed">34221361</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A., Graham A.L. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020;12:194. doi: 10.3390/v12020194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12020194</ArticleId><ArticleId IdType="pmc">PMC7077337</ArticleId><ArticleId IdType="pubmed">32050635</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgendy S.O., Elgendy M.O., El-Gendy A.O., Hamied A.M.A., Al Amir K., Gad R.A., Fahmy A.M. Health Care Workers’ Awareness about the Post-COVID Syndrome and Different Types of COVID-19 Vaccines in Egypt. NeuroQuantology. 2022;20:3830–3839.</Citation></Reference><Reference><Citation>Fahmy A.M., Elgendy M.O., Khalaf A.M., Abdelrahman M.A., Abdelrahim M.E., El-Gendy A.O. COVID-19 Patients with Hepatic Complications During the Third Wave of Pandemic in Egypt. J. Clin. Nurs. Res. 2022;6:108–121. doi: 10.26689/jcnr.v6i3.3726.</Citation><ArticleIdList><ArticleId IdType="doi">10.26689/jcnr.v6i3.3726</ArticleId></ArticleIdList></Reference><Reference><Citation>Vásconez-González J., Fernandez-Naranjo R., Izquierdo-Condoy J.S., Delgado-Moreira K., Cordovez S., Tello-De-la-Torre A., Paz C., Castillo D., Izquierdo-Condoy N., Carrington S.J. Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women. J. Infect. Public Health. 2023;16:430–440. doi: 10.1016/j.jiph.2023.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.01.012</ArticleId><ArticleId IdType="pmc">PMC9851727</ArticleId><ArticleId IdType="pubmed">36736066</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban M., Elgendy M.O., Fahmy A.M., Khalil D.M., El-Gendy A.O., Mahmoud T.M., Abdelrahim M.E. The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report. J. Pers. Med. 2022;12:1822. doi: 10.3390/jpm12111822.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12111822</ArticleId><ArticleId IdType="pmc">PMC9699476</ArticleId><ArticleId IdType="pubmed">36579556</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdou L.M., El-Gendy A.O., Elgendy M.O., Gad R.A., Elgendy S.O., Eid R.A., Sayed A.M., Mahmoud T.M. The Impact of Combining Cefepime or Ceftazidime with Steroidal and Anticoagulant Therapy in the Treatment of COVID-19 Patients. NeuroQuantology. 2022;20:3696–3701.</Citation></Reference><Reference><Citation>Narang K., Enninga E.A.L., Gunaratne M.D., Ibirogba E.R., Trad A.T.A., Elrefaei A., Theiler R.N., Ruano R., Szymanski L.M., Chakraborty R. Mayo Clinic Proceedings. Elsevier; Amsterdam, The Netherlands: 2020. SARS-CoV-2 infection and COVID-19 during pregnancy: A multidisciplinary review; pp. 1750–1765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260486</ArticleId><ArticleId IdType="pubmed">32753148</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashraath P., Wong J.L.J., Lim M.X.K., Lim L.M., Li S., Biswas A., Choolani M., Mattar C., Su L.L. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am. J. Obstet. Gynecol. 2020;222:521–531. doi: 10.1016/j.ajog.2020.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.03.021</ArticleId><ArticleId IdType="pmc">PMC7270569</ArticleId><ArticleId IdType="pubmed">32217113</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar H., Patel C., Abuelgasim E., Harky A. COVID-19 (SARS-CoV-2) infection in pregnancy: A systematic review. Gynecol. Obstet. Investig. 2020;85:295–306. doi: 10.1159/000509290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509290</ArticleId><ArticleId IdType="pmc">PMC7490507</ArticleId><ArticleId IdType="pubmed">32728006</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman M.A., Zaki A., Salem S.A., Salem H.F., Ibrahim A.R., Hassan A., Elgendy M.O. The Impact of Cefepime and Ampicillin/Sulbactam on Preventing Post-Cesarean Surgical Site Infections, Randomized Controlled Trail. Antibiotics. 2023;12:1666. doi: 10.3390/antibiotics12121666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12121666</ArticleId><ArticleId IdType="pmc">PMC10740998</ArticleId><ArticleId IdType="pubmed">38136700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Jiang Y., Wei M., Cheng B., Zhou X., Li J., Tian J., Dong L., Hu R. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua Fu Chan Ke Za Zhi. 2020;55:166–171.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145714</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghavi S.-A., Heidari S., Jahanfar S., Amirjani S., Aji-Ramkani A., Azizi-Kutenaee M., Bazarganipour F. Obstetric, maternal, and neonatal outcomes in COVID-19 compared to healthy pregnant women in Iran: A retrospective, case-control study. Middle East Fertil. Soc. J. 2021;26:1–8. doi: 10.1186/s43043-021-00059-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43043-021-00059-2</ArticleId><ArticleId IdType="pmc">PMC8202219</ArticleId><ArticleId IdType="pubmed">34149282</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Yin K. Management of pregnant women infected with COVID-19. Lancet Infect. Dis. 2020;20:513–514. doi: 10.1016/S1473-3099(20)30191-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30191-2</ArticleId><ArticleId IdType="pmc">PMC7156224</ArticleId><ArticleId IdType="pubmed">32220285</ArticleId></ArticleIdList></Reference><Reference><Citation>Asnafi N., Hajian K. Mid-trimester uterine artery Doppler ultrasound as a predictor of adverse obstetric outcome in high-risk pregnancy. Taiwan. J. Obstet. Gynecol. 2011;50:29–32. doi: 10.1016/j.tjog.2009.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tjog.2009.08.002</ArticleId><ArticleId IdType="pubmed">21482371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>